Lumos Diagnostics Holdings Limited
LDXHF
$0.015
$0.000.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 127.98% | 127.98% | 53.54% | 53.54% | -45.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 127.98% | 127.98% | 53.54% | 53.54% | -45.63% |
| Cost of Revenue | 66.29% | 66.29% | 30.68% | 30.68% | -54.54% |
| Gross Profit | 178.33% | 178.33% | 72.60% | 72.60% | -35.27% |
| SG&A Expenses | 8.41% | 8.41% | 2.10% | 2.10% | -2.63% |
| Depreciation & Amortization | 3.86% | 3.86% | -18.69% | -18.69% | -33.61% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.41% | 16.41% | 5.35% | 5.35% | -23.00% |
| Operating Income | 38.40% | 38.40% | 54.10% | 54.10% | 3.21% |
| Income Before Tax | 56.28% | 56.28% | 9.47% | 9.47% | 2.30% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 56.28% | 56.28% | 9.47% | 9.47% | 2.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 56.28% | 56.28% | 9.47% | 9.47% | 2.30% |
| EBIT | 38.40% | 38.40% | 54.10% | 54.10% | 3.21% |
| EBITDA | 51.01% | 51.01% | 56.07% | 59.08% | -12.10% |
| EPS Basic | 68.06% | 68.06% | 50.00% | 50.00% | 53.85% |
| Normalized Basic EPS | 68.89% | 68.89% | 74.55% | 74.55% | 50.00% |
| EPS Diluted | 68.06% | 68.06% | 50.00% | 50.00% | 53.85% |
| Normalized Diluted EPS | 68.89% | 68.89% | 74.55% | 74.55% | 50.00% |
| Average Basic Shares Outstanding | 37.92% | 37.92% | 85.53% | 85.53% | 111.72% |
| Average Diluted Shares Outstanding | 37.92% | 37.92% | 85.53% | 85.53% | 111.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
